T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab
Research output: Contribution to journal › Journal article › Research › peer-review
T cells influence outcome in follicular lymphoma, but their contributions seem to be modified by therapy. Their impact in patients receiving rituximab without chemotherapy is unknown.
| Original language | English |
|---|---|
| Journal | Clinical Cancer Research |
| Volume | 17 |
| Issue number | 12 |
| Pages (from-to) | 4136-44 |
| Number of pages | 9 |
| ISSN | 1078-0432 |
| DOIs | |
| Publication status | Published - 2011 |
ID: 40153567